Matches in SemOpenAlex for { <https://semopenalex.org/work/W2620975046> ?p ?o ?g. }
- W2620975046 endingPage "23" @default.
- W2620975046 startingPage "16" @default.
- W2620975046 abstract "Small cell lung cancer (SCLC) is an aggressive tumor characterized by rapid doubling time and high propensity for early development of disseminated disease. Although most patients respond to initial therapy with a platinum doublet, the majority of those with limited stage and virtually all patients with metastatic disease eventually develop tumor progression for which there are limited treatment options. There have been no recent changes in the treatment of SCLC, with platinum plus etoposide and topotecan as the standard first-line and second-line respectively, neither showing survival benefit over the combination of cyclophosphamide, doxorubicin and vincristine, which was developed in the 1970s. More recently, a new understanding of the biology of SCLC has led to the development of novel drugs, of which the most promising are the immune checkpoint inhibitors and the antibody drug conjugate rovalpituzumab tesirine." @default.
- W2620975046 created "2017-06-09" @default.
- W2620975046 creator A5031420337 @default.
- W2620975046 creator A5080011474 @default.
- W2620975046 date "2017-12-01" @default.
- W2620975046 modified "2023-10-01" @default.
- W2620975046 title "Treatment advances in small cell lung cancer (SCLC)" @default.
- W2620975046 cites W1822869875 @default.
- W2620975046 cites W1884032213 @default.
- W2620975046 cites W1885320430 @default.
- W2620975046 cites W1898381946 @default.
- W2620975046 cites W1903188031 @default.
- W2620975046 cites W1905406155 @default.
- W2620975046 cites W1919288105 @default.
- W2620975046 cites W1932169383 @default.
- W2620975046 cites W1952431753 @default.
- W2620975046 cites W1965274188 @default.
- W2620975046 cites W1971264126 @default.
- W2620975046 cites W1973510243 @default.
- W2620975046 cites W1978286483 @default.
- W2620975046 cites W1979932133 @default.
- W2620975046 cites W1980269766 @default.
- W2620975046 cites W1981137973 @default.
- W2620975046 cites W1996506613 @default.
- W2620975046 cites W2000159952 @default.
- W2620975046 cites W2011868684 @default.
- W2620975046 cites W2016722600 @default.
- W2620975046 cites W2019041562 @default.
- W2620975046 cites W2023171799 @default.
- W2620975046 cites W2049553585 @default.
- W2620975046 cites W2053144322 @default.
- W2620975046 cites W2054935156 @default.
- W2620975046 cites W2056631765 @default.
- W2620975046 cites W2065188377 @default.
- W2620975046 cites W2070965927 @default.
- W2620975046 cites W2073683299 @default.
- W2620975046 cites W2074462509 @default.
- W2620975046 cites W2074999094 @default.
- W2620975046 cites W2083904374 @default.
- W2620975046 cites W2095475448 @default.
- W2620975046 cites W2101156795 @default.
- W2620975046 cites W2103702213 @default.
- W2620975046 cites W2103786242 @default.
- W2620975046 cites W2108927999 @default.
- W2620975046 cites W2117692326 @default.
- W2620975046 cites W2120435735 @default.
- W2620975046 cites W2123767004 @default.
- W2620975046 cites W2124353451 @default.
- W2620975046 cites W2124473529 @default.
- W2620975046 cites W2129638180 @default.
- W2620975046 cites W2131664752 @default.
- W2620975046 cites W2136290128 @default.
- W2620975046 cites W2136537241 @default.
- W2620975046 cites W2138683149 @default.
- W2620975046 cites W2140487914 @default.
- W2620975046 cites W2142055223 @default.
- W2620975046 cites W2143772132 @default.
- W2620975046 cites W2153423658 @default.
- W2620975046 cites W2156537375 @default.
- W2620975046 cites W2158127925 @default.
- W2620975046 cites W2160012348 @default.
- W2620975046 cites W2164922431 @default.
- W2620975046 cites W2166392962 @default.
- W2620975046 cites W2166418266 @default.
- W2620975046 cites W2170260373 @default.
- W2620975046 cites W2209593766 @default.
- W2620975046 cites W2260064945 @default.
- W2620975046 cites W2263979489 @default.
- W2620975046 cites W2301784755 @default.
- W2620975046 cites W2323020638 @default.
- W2620975046 cites W2339444986 @default.
- W2620975046 cites W2341745217 @default.
- W2620975046 cites W2350390677 @default.
- W2620975046 cites W2415283090 @default.
- W2620975046 cites W2418354692 @default.
- W2620975046 cites W2419167533 @default.
- W2620975046 cites W2468369037 @default.
- W2620975046 cites W2529738115 @default.
- W2620975046 cites W2531272164 @default.
- W2620975046 cites W2560431464 @default.
- W2620975046 cites W2576845640 @default.
- W2620975046 cites W2597045666 @default.
- W2620975046 cites W2598659203 @default.
- W2620975046 doi "https://doi.org/10.1016/j.pharmthera.2017.06.002" @default.
- W2620975046 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28579387" @default.
- W2620975046 hasPublicationYear "2017" @default.
- W2620975046 type Work @default.
- W2620975046 sameAs 2620975046 @default.
- W2620975046 citedByCount "127" @default.
- W2620975046 countsByYear W26209750462017 @default.
- W2620975046 countsByYear W26209750462018 @default.
- W2620975046 countsByYear W26209750462019 @default.
- W2620975046 countsByYear W26209750462020 @default.
- W2620975046 countsByYear W26209750462021 @default.
- W2620975046 countsByYear W26209750462022 @default.
- W2620975046 countsByYear W26209750462023 @default.
- W2620975046 crossrefType "journal-article" @default.
- W2620975046 hasAuthorship W2620975046A5031420337 @default.